Sellas Life Sciences Group Inc. SLS, -53.25% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy stock. Shares of the biopharmaceutical company, whic...
Tag: iShares Biotechnology ETF
Cingulate stock skyrockets after ADHD treatment shows positive trial results
Shares of Cingulate Inc. CING, +51.30% skyrocketed 82.9% toward an 11-month high in active premarket trading Friday, after the biopharmaceutical company reported positive results from a trial of its a...
Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +60.35% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regar...
Kala Pharmaceuticals stock rockets nearly 300% after FDA OKs IND application for PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +219.90% quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational...
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
If you want to know how much investors hate the biotech sector right now, consider this simple statistic: More than 25% of small biotech companies have stock-market capitalizations that are smaller th...
Get ready for the climb. Here’s what history says about stock-market returns during Fed rate-hike cycles.
Bond yields are rising again so far in 2022. The U.S. stock market seems vulnerable to a bona fide correction. But what can you really tell from a mere two weeks into a new year? Not much and quite a ...
Biotech Stocks Are Due to Bounce Back. This One Stands Out.
Text size Large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive. Igor Akimov/Dreamstime.com Biotech stocks began the year in much the same way they ended...
Fate Therapeutics stocks heads for record selloff after Janssen collaboration terminated and job cuts
Shares of Fate Therapeutics Inc. FATE, -61.18% plunged 56.8% in premarket trading, putting them on track for a record one-day selloff, after the biopharmaceutical company announced the termination of ...